Kentucky · 2025 Regular Session · Bill
HB 501: AN ACT relating to pharmaceutical drugs.
Enacted Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 501 is a bill introduced in the Kentucky House on February 13, 2025. According to its official title, it concerns: AN ACT relating to pharmaceutical drugs. Most recent recorded action (April 10, 2025): became law without Governor's Signature (Acts Ch. 161).
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Create a new section of KRS Chapter 315 to establish requirements for pharmacists when dispensing prescriptions in the event of a practitioner's death.
Sponsors
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| No sponsor recorded in source data. | ||||
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- became law without Governor's Signature (Acts Ch. 161)
- filed without Governor's signature with the Secretary of State
- delivered to Governor
- enrolled, signed by President of the Senate
- enrolled, signed by Speaker of the House
- passed 83-16
- House concurred in Senate Floor Amendment (2) and Floor Amendment (1-title)
- posted for passage for concurrence in Senate Floor Amendment (2) and Floor Amendment (1-title)
- to Rules (H)
- received in House
- 3rd reading, passed 38-0 with Floor Amendment (2) and Floor Amendment (1-title)
- posted for passage in the Regular Orders of the Day for Friday, March 28, 2025
Showing 12 most recent of 26 actions. Full history